Kelly Huller
CIK 1768417 · View on SEC EDGAR ↗
First SEC filing: March 6, 2019 · Latest: March 6, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | GMED | S 10b5-1 | 20,000 | $94.50 | $1,890,000 | 0 Direct | -100.00% | Disposed | -6.7% (price as of 2026-08-20) |
| Feb. 12, 2026 | GMED | S 10b5-1 | 10,000 | $87.67 | $876,700 | 0 Direct | -100.00% | Disposed | 0.6% (price as of 2026-08-20) |
| Nov. 25, 2025 | GMED | S 10b5-1 | 7,500 | $90.00 | $675,000 | 0 Direct | -100.00% | Disposed | -2.0% (price as of 2026-08-20) |
| Dec. 2, 2024 | GMED | S 10b5-1 | 2,500 | $87.00 | $217,500 | 0 Direct | -100.00% | Disposed | 1.4% (price as of 2026-08-20) |
| Nov. 6, 2024 | GMED | S 10b5-1 | 2,500 | $82.00 | $205,000 | 0 Direct | -100.00% | Disposed | 7.6% (price as of 2026-08-20) |
| Nov. 6, 2024 | GMED | S 10b5-1 | 2,500 | $80.02 | $200,050 | 2,500 Direct | -50.00% | Disposed | 10.2% (price as of 2026-08-20) |
| Oct. 16, 2024 | GMED | S 10b5-1 | 7,500 | $75.02 | $562,650 | — Direct | — | Disposed | 17.6% (price as of 2026-08-20) |
| March 1, 2024 | GMED | S 10b5-1 | 3,115 | $54.53 | $169,861 | 0 Direct | -100.00% | Disposed | 61.8% (price as of 2026-08-20) |
| March 1, 2024 | GMED | S 10b5-1 | 4,385 | $53.79 | $235,869 | 3,115 Direct | -58.47% | Disposed | 64.0% (price as of 2026-08-20) |
| Dec. 1, 2022 | GMED | S 10b5-1 | 7,500 | $75.00 | $562,500 | 0 Direct | -100.00% | Disposed | 17.6% (price as of 2026-08-20) |
| April 8, 2022 | GMED | S 10b5-1 | 2,500 | $75.58 | $188,950 | 0 Direct | -100.00% | Disposed | 16.7% (price as of 2026-08-20) |
| Dec. 28, 2020 | GMED | S 10b5-1 | 2,000 | $66.15 | $132,300 | 0 Direct | -100.00% | Disposed | 33.3% (price as of 2026-08-20) |
| Aug. 6, 2020 | GMED | S 10b5-1 | 3,000 | $57.90 | $173,700 | 0 Direct | -100.00% | Disposed | 52.3% (price as of 2026-08-20) |
| Aug. 6, 2020 | GMED | S 10b5-1 | 3,000 | $55.92 | $167,760 | 3,000 Direct | -50.00% | Disposed | 57.7% (price as of 2026-08-20) |
| Aug. 6, 2020 | GMED | S 10b5-1 | 6,000 | $54.78 | $328,680 | 6,000 Direct | -50.00% | Disposed | 61.0% (price as of 2026-08-20) |
| June 11, 2020 | GMED | S 10b5-1 | 9,076 | $51.00 | $462,876 | 0 Direct | -100.00% | Disposed | 73.0% (price as of 2026-08-20) |
| Dec. 17, 2019 | GMED | S 10b5-1 | 6,460 | $58.90 | $380,494 | 0 Direct | -100.00% | Disposed | 49.8% (price as of 2026-08-20) |
| Nov. 7, 2019 | GMED | S 10b5-1 | 3,000 | $55.90 | $167,700 | 3,384 Direct | -46.99% | Disposed | 57.8% (price as of 2026-08-20) |
| Nov. 1, 2019 | GMED | S 10b5-1 | 3,000 | $52.90 | $158,700 | 6,384 Direct | -31.97% | Disposed | 66.7% (price as of 2026-08-20) |
| Aug. 2, 2019 | GMED | S 10b5-1 | 3,000 | $49.90 | $149,700 | 9,384 Direct | -24.22% | Disposed | 76.8% (price as of 2026-08-20) |
| March 28, 2019 | GMED | S 10b5-1 | 3,000 | $48.59 | $145,770 | 12,384 Direct | -19.50% | Disposed | 81.5% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (20,000) | $43.58 | Jan. 22, 2029 | 20,000 | Disposed |
| Feb. 12, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (10,000) | $45.64 | Feb. 2, 2028 | 10,000 | Disposed |
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40,000) | $94.15 | Jan. 21, 2036 | 40,000 | Acquired |
| Nov. 25, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (7,500) | $25.96 | Feb. 2, 2027 | 7,500 | Disposed |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40,000) | $92.42 | Jan. 23, 2035 | 40,000 | Acquired |
| Dec. 2, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (2,500) | $24.21 | Feb. 2, 2026 | 2,500 | Disposed |
| Nov. 6, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (5,000) | $24.21 | Feb. 2, 2026 | 5,000 | Disposed |
| Oct. 16, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (7,500) | $25.80 | April 1, 2025 | 7,500 | Disposed |
| March 1, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (7,500) | $24.90 | March 4, 2024 | 7,500 | Disposed |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40,000) | $53.75 | Jan. 26, 2034 | 40,000 | Acquired |
| Oct. 10, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (5,000) | $53.02 | Sept. 1, 2033 | 5,000 | Acquired |
| Jan. 26, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (30,000) | $75.18 | Jan. 26, 2033 | 30,000 | Acquired |
| Dec. 1, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (7,500) | $12.59 | Jan. 30, 2023 | 7,500 | Disposed |
| April 8, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (2,500) | $15.34 | Aug. 29, 2022 | 2,500 | Disposed |
| Jan. 27, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (30,000) | $63.68 | Jan. 27, 2032 | 30,000 | Acquired |
| Jan. 14, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (30,000) | $65.05 | Jan. 14, 2031 | 30,000 | Acquired |
| Dec. 28, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (2,000) | $11.28 | Feb. 11, 2021 | 2,000 | Disposed |
| Aug. 6, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (12,000) | $11.28 | Feb. 11, 2021 | 12,000 | Disposed |
| June 11, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (9,076) | $11.28 | Feb. 11, 2021 | 9,076 | Disposed |
| Jan. 22, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (40,000) | $53.27 | Jan. 22, 2030 | 40,000 | Acquired |
| Dec. 17, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock (3,076) | $11.86 | June 16, 2020 | 3,076 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| March 6, 2019 | GMED | Class A Common Stock | 15,384 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (3,076) | 3,076 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (23,076) | 23,076 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (2,500) | 2,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (7,500) | 7,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (7,500) | 7,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (7,500) | 7,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (7,500) | 7,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (7,500) | 7,500 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (10,000) | 10,000 | Direct |
| March 6, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock)→ Class A Common Stock (40,000) | 40,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
GMED
EVP| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $364,075 | $40,000 | — | — | $411,709 | — | $34,578 | $2,280,832 |
| 2024 | $357,265 | — | — | $839,110 | $403,636 | — | $28,612 | $1,628,623 |
| 2023 | $344,210 | $100,000 | — | $910,610 | $258,750 | — | $26,378 | $1,639,948 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.